Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell-derived dopaminergic neurons.

Yoshikawa T, Samata B, Ogura A, Miyamoto S, Takahashi J.

Front Cell Neurosci. 2013 Feb 15;7:11. doi: 10.3389/fncel.2013.00011. eCollection 2013. Erratum in: Front Cell Neurosci. 2013;7:116.

2.

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Sundberg M, Bogetofte H, Lawson T, Jansson J, Smith G, Astradsson A, Moore M, Osborn T, Cooper O, Spealman R, Hallett P, Isacson O.

Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415.

3.

Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.

Chang YL, Chen SJ, Kao CL, Hung SC, Ding DC, Yu CC, Chen YJ, Ku HH, Lin CP, Lee KH, Chen YC, Wang JJ, Hsu CC, Chen LK, Li HY, Chiou SH.

Cell Transplant. 2012;21(1):313-32. doi: 10.3727/096368911X580572. Epub 2011 Jun 7.

PMID:
21669041
4.

Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival.

Lee HS, Bae EJ, Yi SH, Shim JW, Jo AY, Kang JS, Yoon EH, Rhee YH, Park CH, Koh HC, Kim HJ, Choi HS, Han JW, Lee YS, Kim J, Li JY, Brundin P, Lee SH.

Stem Cells. 2010 Mar 31;28(3):501-12. doi: 10.1002/stem.294.

5.

In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons.

Park CH, Minn YK, Lee JY, Choi DH, Chang MY, Shim JW, Ko JY, Koh HC, Kang MJ, Kang JS, Rhie DJ, Lee YS, Son H, Moon SY, Kim KS, Lee SH.

J Neurochem. 2005 Mar;92(5):1265-76.

6.

Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation.

Doi D, Samata B, Katsukawa M, Kikuchi T, Morizane A, Ono Y, Sekiguchi K, Nakagawa M, Parmar M, Takahashi J.

Stem Cell Reports. 2014 Mar 6;2(3):337-50. doi: 10.1016/j.stemcr.2014.01.013. eCollection 2014 Mar 11.

7.

Differentiation of dopaminergic neurons from human embryonic stem cells: modulation of differentiation by FGF-20.

Shimada H, Yoshimura N, Tsuji A, Kunisada T.

J Biosci Bioeng. 2009 Apr;107(4):447-54. doi: 10.1016/j.jbiosc.2008.12.013.

PMID:
19332307
8.

Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats.

Chaturvedi RK, Shukla S, Seth K, Agrawal AK.

Exp Neurol. 2008 Apr;210(2):608-23. doi: 10.1016/j.expneurol.2007.12.016. Epub 2007 Dec 31.

PMID:
18272152
9.

Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes.

Kim DS, Lee DR, Kim HS, Yoo JE, Jung SJ, Lim BY, Jang J, Kang HC, You S, Hwang DY, Leem JW, Nam TS, Cho SR, Kim DW.

PLoS One. 2012;7(7):e39715. doi: 10.1371/journal.pone.0039715. Epub 2012 Jul 20.

10.

Effect of Cell Adhesion Molecules on the Neurite Outgrowth of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons.

Peng SP, Schachner M, Boddeke E, Copray S.

Cell Reprogram. 2016 Apr;18(2):55-66. doi: 10.1089/cell.2015.0059. Epub 2016 Mar 18.

PMID:
26990843
11.

Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.

Glavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan MP, Dugich-Djordjevic M, Bohn MC.

Cell Transplant. 2009;18(7):801-14. doi: 10.3727/096368909X470801. Epub 2009 Sep 28.

PMID:
19796495
12.
13.

Estrogen promotes differentiation and survival of dopaminergic neurons derived from human neural stem cells.

Kishi Y, Takahashi J, Koyanagi M, Morizane A, Okamoto Y, Horiguchi S, Tashiro K, Honjo T, Fujii S, Hashimoto N.

J Neurosci Res. 2005 Feb 1;79(3):279-86.

PMID:
15614791
14.

Extended passaging increases the efficiency of neural differentiation from induced pluripotent stem cells.

Koehler KR, Tropel P, Theile JW, Kondo T, Cummins TR, Viville S, Hashino E.

BMC Neurosci. 2011 Aug 10;12:82. doi: 10.1186/1471-2202-12-82.

15.

Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons.

Rössler R, Boddeke E, Copray S.

Neuroscience. 2010 Oct 13;170(2):417-28. doi: 10.1016/j.neuroscience.2010.07.023. Epub 2010 Jul 17.

PMID:
20643196
16.

Induction of midbrain dopaminergic neurons from primate embryonic stem cells by coculture with sertoli cells.

Yue F, Cui L, Johkura K, Ogiwara N, Sasaki K.

Stem Cells. 2006 Jul;24(7):1695-706.

17.

Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.

Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.

Brain. 2010 Jan;133(Pt 1):189-204. doi: 10.1093/brain/awp290. Epub 2009 Dec 7.

PMID:
19995872
18.

The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease.

Ratzka A, Kalve I, Özer M, Nobre A, Wesemann M, Jungnickel J, Köster-Patzlaff C, Baron O, Grothe C.

Cell Transplant. 2012;21(4):749-62. doi: 10.3727/096368911X586774. Epub 2011 Sep 16.

PMID:
21929871
19.

Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions.

Swistowski A, Peng J, Liu Q, Mali P, Rao MS, Cheng L, Zeng X.

Stem Cells. 2010 Oct;28(10):1893-904. doi: 10.1002/stem.499.

20.

Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.

Nishino H, Hida H, Takei N, Kumazaki M, Nakajima K, Baba H.

Exp Neurol. 2000 Jul;164(1):209-14.

PMID:
10877931

Supplemental Content

Support Center